Next Article in Journal
Genetic Modifications to Alter Blood Pressure Level
Next Article in Special Issue
Mitochondrial Ca2+ Signaling and Bioenergetics in Alzheimer’s Disease
Previous Article in Journal
Single and Repeated Exposure to Cannabidiol Differently Modulate BDNF Expression and Signaling in the Cortico-Striatal Brain Network
Previous Article in Special Issue
Activation of the Mitochondrial Unfolded Protein Response: A New Therapeutic Target?
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Special Issue “Mitochondria and Brain Disease”

by
Susana Cardoso
1,2,3
1
Center for Neuroscience and Cell Biology (CNC), University of Coimbra, 3004-504 Coimbra, Portugal
2
Institute for Interdisciplinary Research (IIIU), University of Coimbra, 3030-789 Coimbra, Portugal
3
Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3004-504 Coimbra, Portugal
Biomedicines 2022, 10(8), 1854; https://doi.org/10.3390/biomedicines10081854
Submission received: 21 July 2022 / Accepted: 23 July 2022 / Published: 1 August 2022
(This article belongs to the Special Issue Mitochondria and Brain Disease)
We are pleased to present the first Special Issue (SI) of “Mitochondria and Brain Disease”. The scope of the present SI was to collect papers devoted to the multifaceted investigation of mitochondrial function and mitochondrial-directed interventions in the broad and heterogeneous field of brain diseases. Several renowned researchers contributed to this diverse collection, which includes five original research articles and eleven literature reviews. Topics addressed in this SI include the comprehensive discussion of mitochondrial function in early life stress (ELS)-affected brain [1], as well as in age-related neurodegenerative disorders such as Parkinson’s (PD) [2] and Alzheimer’s diseases (AD) [3]. In the same line, Leal and Martins [4] provide an updated review on the involvement of mitochondria–endoplasmic reticulum contact sites (MERCS) in neurodegenerative disorders, in particular AD. In turn, Onyango et al. [5] discuss the interaction between age-related mechanisms of disease (i.e., mitochondrial dysfunction, oxidative stress, defective autophagy, cellular senescence, etc.) and neuroinflammation in the pathogenesis of late-onset AD. A different perspective is presented by Bennett and Onyango [6] that discuss the involvement of mitochondria in age-related diseases from a thermodynamic point-of-view. In addition, a review manuscript by Brunetti et al. [7] discusses the role of defective mitochondrial proteostasis, namely due to the dysfunctional activity of pitrilysin metallopeptidase 1 (PITRM1), as a possible driving factor of several neurodegenerative conditions, particularly AD. Likely, another review manuscript by Lucini and Braun [8] discusses the role of mitochondria in TDP-43 proteinopathy and the involvement of TDP-43-mediated mitochondrial dysfunction in neurodegenerative diseases. In turn, the study of Kurokin et al. [9] shows that changes in lipid classes within mitochondria may correlate with the APP processing, i.e., whether it goes through the amyloidogenic or non- amyloidogenic pathway, and may compromise mitochondrial function. In the context of mental disorders, the review manuscript by Bressan and Kramer [10] presents a broad perspective on how mental disease relates to the different evolutionary strategies of men and women and to growth, metabolism, and mitochondria. In addition, Marques et al. [11] demonstrate that the loss of mitochondrial function is an early event implicated in bipolar disorder pathophysiology that might trigger neuronal changes and the modification of brain circuitry. The role of mitochondria in ischemic stroke and I/R injury is also discussed by Carinci et al. [12] who comprehensibly review the principal mitochondrial molecular mechanisms that function during the insults and present potential neuroprotective strategies targeting mitochondrial dysfunction and mitochondrial homeostasis. The importance of mitochondria in the cascade of events regulated by the IGF1/IGF1R signalling pathway is also described by Cardoso et al. [13]. In the same line, Lu et al. [14] demonstrate that mitochondrial function is improved in an animal model of epilepsy treated with medicinal plant-derived substances. Finally, this SI comprises two manuscripts that address the importance of mitochondria in oligodendrocyte function. One of those is an original study reporting that mitochondria is an important mediator in the loss of oligodendrocytes and myelin that characterizes Krabbe disease (KD) [15]. The other one discusses the role of mitochondria and endoplasmic reticulum in the malfunction of oligodendrocytes induced by harmful exogenous stimuli [16].
Given all these varied contributions, it is clear that mitochondria are powerful organelles that enable our existence, and the disruption of its function is theorized to have a causative role in several brain-related diseases. Importantly, these studies also highlight the therapeutic potential of rescuing mitochondrial integrity in such brain-related pathologies. There are still many important questions that remain unanswered, promising a great future for this field.

Funding

This research received no external funding.

Acknowledgments

I would like to sincerely thank all the authors for their valuable contributions. S.C. has a Post-Doctoral Researcher Contract DL57/2016 (#SFRH/BPD/95770/2013) from FCT - Foundation for Science and Technology.

Conflicts of Interest

The author declares no conflict of interest.

References

  1. Salmina, A.B.; Gorina, Y.V.; Komleva, Y.K.; Panina, Y.A.; Malinovskaya, N.A.; Lopatina, O.L. Early Life Stress and Metabolic Plasticity of Brain Cells: Impact on Neurogenesis and Angiogenesis. Biomedicines 2021, 9, 1092. [Google Scholar] [CrossRef] [PubMed]
  2. Buneeva, O.; Fedchenko, V.; Kopylov, A.; Medvedev, A. Mitochondrial Dysfunction in Parkinson’s Disease: Focus on Mitochondrial DNA. Biomedicines 2020, 8, 591. [Google Scholar] [CrossRef] [PubMed]
  3. Bell, S.M.; Barnes, K.; De Marco, M.; Shaw, P.J.; Ferraiuolo, L.; Blackburn, D.J.; Venneri, A.; Mortiboys, H. Mitochondrial Dysfunction in Alzheimer’s Disease: A Biomarker of the Future? Biomedicines 2021, 9, 63. [Google Scholar] [CrossRef] [PubMed]
  4. Leal, N.S.; Martins, L.M. Mind the Gap: Mitochondria and the Endoplasmic Reticulum in Neurodegenerative Diseases. Biomedicines 2021, 9, 227. [Google Scholar] [CrossRef] [PubMed]
  5. Onyango, I.G.; Jauregui, G.V.; Čarná, M.; Bennett, J.P., Jr.; Stokin, G.B. Neuroinflammation in Alzheimer’s Disease. Biomedicines 2021, 9, 524. [Google Scholar] [CrossRef] [PubMed]
  6. Bennett, J.P., Jr.; Onyango, I.G. Energy, Entropy and Quantum Tunneling of Protons and Electrons in Brain Mitochondria: Relation to Mitochondrial Impairment in Aging-Related Human Brain Diseases and Therapeutic Measures. Biomedicines 2021, 9, 225. [Google Scholar] [CrossRef] [PubMed]
  7. Brunetti, D.; Catania, A.; Viscomi, C.; Deleidi, M.; Bindoff, L.A.; Ghezzi, D.; Zeviani, M. Role of PITRM1 in Mitochondrial Dysfunction and Neurodegeneration. Biomedicines 2021, 9, 833. [Google Scholar] [CrossRef] [PubMed]
  8. Lucini, C.B.; Braun, R.J. Mitochondrion-Dependent Cell Death in TDP-43 Proteinopathies. Biomedicines 2021, 9, 376. [Google Scholar] [CrossRef] [PubMed]
  9. Kurokin, I.; Lauer, A.A.; Janitschke, D.; Winkler, J.; Theiss, E.L.; Griebsch, L.V.; Pilz, S.M.; Matschke, V.; van der Laan, M.; Grimm, H.S.; et al. Targeted Lipidomics of Mitochondria in a Cellular Alzheimer’s Disease Model. Biomedicines 2021, 9, 1062. [Google Scholar] [CrossRef] [PubMed]
  10. Bressan, P.; Kramer, P. Mental Health, Mitochondria, and the Battle of the Sexes. Biomedicines 2021, 9, 116. [Google Scholar] [CrossRef] [PubMed]
  11. Marques, A.P.; Resende, R.; Silva, D.F.; Batista, M.; Pereira, D.; Wildenberg, B.; Morais, S.; Macedo, A.; Pais, C.; Melo, J.B.; et al. Mitochondrial Alterations in Fibroblasts of Early Stage Bipolar Disorder Patients. Biomedicines 2021, 9, 522. [Google Scholar] [CrossRef] [PubMed]
  12. Carinci, M.; Vezzani, B.; Patergnani, S.; Ludewig, P.; Lessmann, K.; Magnus, T.; Casetta, I.; Pugliatti, M.; Pinton, P.; Giorgi, C. Different Roles of Mitochondria in Cell Death and Inflammation: Focusing on Mitochondrial Quality Control in Ischemic Stroke and Reperfusion. Biomedicines 2021, 9, 169. [Google Scholar] [CrossRef] [PubMed]
  13. Cardoso, S.; López, I.P.; Piñeiro-Hermida, S.; Pichel, J.G.; Moreira, P.I. IGF1R Deficiency Modulates Brain Signaling Pathways and Disturbs Mitochondria and Redox Homeostasis. Biomedicines 2021, 9, 158. [Google Scholar] [CrossRef] [PubMed]
  14. Lu, C.-W.; Lin, T.-Y.; Pan, T.-L.; Wang, P.-W.; Chiu, K.-M.; Lee, M.-Y.; Wang, S.-J. Asiatic Acid Prevents Cognitive Deficits by Inhibiting Calpain Activation and Preserving Synaptic and Mitochondrial Function in Rats with Kainic Acid-Induced Seizure. Biomedicines 2021, 9, 284. [Google Scholar] [CrossRef] [PubMed]
  15. Cheng, A.; Kawahata, I.; Fukunaga, K. Fatty Acid Binding Protein 5 Mediates Cell Death by Psychosine Exposure through Mitochondrial Macropores Formation in Oligodendrocytes. Biomedicines 2020, 8, 635. [Google Scholar] [CrossRef] [PubMed]
  16. Maiuolo, J.; Gliozzi, M.; Musolino, V.; Carresi, C.; Nucera, S.; Scicchitano, M.; Scarano, F.; Bosco, F.; Oppedisano, F.; Macrì, R.; et al. Environmental and Nutritional “Stressors” and Oligodendrocyte Dysfunction: Role of Mitochondrial and Endoplasmatic Reticulum Impairment. Biomedicines 2020, 8, 553. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Cardoso, S. Special Issue “Mitochondria and Brain Disease”. Biomedicines 2022, 10, 1854. https://doi.org/10.3390/biomedicines10081854

AMA Style

Cardoso S. Special Issue “Mitochondria and Brain Disease”. Biomedicines. 2022; 10(8):1854. https://doi.org/10.3390/biomedicines10081854

Chicago/Turabian Style

Cardoso, Susana. 2022. "Special Issue “Mitochondria and Brain Disease”" Biomedicines 10, no. 8: 1854. https://doi.org/10.3390/biomedicines10081854

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop